| 000 | 01195 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250518015929.0 | ||
| 264 | 0 | _c20190425 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a1878-0334 | ||
| 024 | 7 |
_a10.1016/j.dsx.2018.11.054 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aA/L B Vasanth Rao, Vikram Rao | |
| 245 | 0 | 0 |
_aDiabetic nephropathy: An update on pathogenesis and drug development. _h[electronic resource] |
| 260 |
_bDiabetes & metabolic syndrome _c |
||
| 300 |
_a754-762 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xdiagnosis |
| 650 | 0 | 4 |
_aDipeptidyl-Peptidase IV Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aDrug Development _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation Mediators _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSodium-Glucose Transporter 2 Inhibitors _xpharmacology |
| 700 | 1 | _aTan, Sean Hong | |
| 700 | 1 | _aCandasamy, Mayuren | |
| 700 | 1 | _aBhattamisra, Subrat Kumar | |
| 773 | 0 |
_tDiabetes & metabolic syndrome _gvol. 13 _gno. 1 _gp. 754-762 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.dsx.2018.11.054 _zAvailable from publisher's website |
| 999 |
_c29252889 _d29252889 |
||